Dehai Wu

541 total citations
15 papers, 270 citations indexed

About

Dehai Wu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Dehai Wu has authored 15 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Cancer Research. Recurrent topics in Dehai Wu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Ferroptosis and cancer prognosis (3 papers) and RNA modifications and cancer (3 papers). Dehai Wu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Ferroptosis and cancer prognosis (3 papers) and RNA modifications and cancer (3 papers). Dehai Wu collaborates with scholars based in China, Canada and United States. Dehai Wu's co-authors include Hongrui Guo, Shuhang Liang, Shugeng Zhang, Lianxin Liu, Sheng Tai, Yifeng Cui, Jiabei Wang, Kun Ma, Mitesh J. Borad and Catherine D. Moser and has published in prestigious journals such as Cancer Research, Oncogene and Life Sciences.

In The Last Decade

Dehai Wu

14 papers receiving 269 citations

Peers

Dehai Wu
Jinyu Xiang China
Ningjia Shen China
Shenglei Li China
Liguang Yang China
Hailing Jin United States
Lin‐Hai Yan China
Hou-zhong Ding China
Hae Yoen Jung South Korea
Jin‐Ling Duan China
Jinyu Xiang China
Dehai Wu
Citations per year, relative to Dehai Wu Dehai Wu (= 1×) peers Jinyu Xiang

Countries citing papers authored by Dehai Wu

Since Specialization
Citations

This map shows the geographic impact of Dehai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dehai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dehai Wu more than expected).

Fields of papers citing papers by Dehai Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dehai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dehai Wu. The network helps show where Dehai Wu may publish in the future.

Co-authorship network of co-authors of Dehai Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Dehai Wu. A scholar is included among the top collaborators of Dehai Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dehai Wu. Dehai Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhang, Congyi, Dehai Wu, Guanqun Liao, et al.. (2024). The scaffold of neutrophil extracellular traps promotes CCA progression and modulates angiogenesis via ITGAV/NFκB. Cell Communication and Signaling. 22(1). 103–103. 13 indexed citations
2.
3.
Wu, Dehai, Guanqun Liao, Yuanfei Yao, et al.. (2023). Downregulated Acetyl-CoA Acyltransferase 2 Promoted the Progression of Hepatocellular Carcinoma and Participated in the Formation of Immunosuppressive Microenvironment. Journal of Hepatocellular Carcinoma. Volume 10. 1327–1339. 2 indexed citations
4.
Wu, Dehai, Shuhang Liang, Hongrui Guo, et al.. (2022). Downregulation of MARC2 Promotes Immune Escape and Is Associated With Immunosuppression of Hepatocellular Carcinoma. Frontiers in Genetics. 12. 790093–790093. 6 indexed citations
5.
Wu, Dehai, Congyi Zhang, Guanqun Liao, et al.. (2022). Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma. Cellular & Molecular Biology Letters. 27(1). 105–105. 14 indexed citations
6.
Liang, Shuhang, Hongrui Guo, Kun Ma, et al.. (2021). A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression. Cancer Research. 81(23). 5889–5903. 63 indexed citations
7.
Zhang, Shugeng, Shuhang Liang, Dehai Wu, et al.. (2021). LncRNA coordinates Hippo and mTORC1 pathway activation in cancer. Cell Death and Disease. 12(9). 822–822. 10 indexed citations
8.
Yang, Guangchao, Yuanfei Yao, Dehai Wu, et al.. (2020). Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC). Life Sciences. 263. 118576–118576. 2 indexed citations
9.
10.
Cui, Yifeng, Shuhang Liang, Shugeng Zhang, et al.. (2020). ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway. Journal of Experimental & Clinical Cancer Research. 39(1). 90–90. 32 indexed citations
11.
Liao, Guanqun, Xiaopeng Liu, Dehai Wu, et al.. (2019). MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p. Aging. 11(11). 3639–3649. 24 indexed citations
12.
Wu, Dehai, Hao Liang, Shounan Lu, et al.. (2018). miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism. Cellular Physiology and Biochemistry. 50(3). 924–935. 44 indexed citations
13.
Miyabe, Katsuyuki, Yu Wang, Dehai Wu, et al.. (2018). Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma. Translational Oncology. 12(1). 143–153. 35 indexed citations
14.
Wu, Dehai, Liang Hao, Hao Wang, et al.. (2018). Hepatitis B virus‑X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma. Oncology Letters. 16(4). 4418–4426. 9 indexed citations
15.
Wu, Dehai. (2014). Molecular mechanism of hepatitis B virus X-associated hepatocarcinogenesis. World Chinese Journal of Digestology. 22(25). 3773–3773. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinyu Xiang Breakdown of academic impact, for papers by Ningjia Shen Breakdown of academic impact, for papers by Shenglei Li Breakdown of academic impact, for papers by Liguang Yang Breakdown of academic impact, for papers by Hailing Jin Breakdown of academic impact, for papers by Lin‐Hai Yan Breakdown of academic impact, for papers by Hou-zhong Ding Breakdown of academic impact, for papers by Hae Yoen Jung Breakdown of academic impact, for papers by Jin‐Ling Duan
Rankless by CCL
2026